Impax Asset Management Group PLC Regeneron Pharmaceuticals, Inc. Transaction History
Impax Asset Management Group PLC
- $14.9 Billion
- Q1 2025
A detailed history of Impax Asset Management Group PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Impax Asset Management Group PLC holds 1,228 shares of REGN stock, worth $593,209. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,228
Previous 2,613
53.0%
Holding current value
$593,209
Previous $1.86 Million
58.19%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding REGN
# of Institutions
1,470Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$4.54 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.08 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$2.73 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.31 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$1.93 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $51.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...